Capitalized Software Development Costs (Notes)	9 Months Ended
Sep. 30, 2019
Capitalized Software Development Costs Disclosure [Abstract]
Research, Development, and Computer Software Disclosure [Text Block]	Capitalized Software Development Costs In accordance with the relevant authoritative accounting literature, the Company has capitalized certain software and product related development costs associated with both the Company’s continuing medical education service offerings, the Company’s development of its property and casualty underwriting insurance data exchange platform servicing the London markets, and mobile applications and software enhancements under development for its EbixCash products. During the nine months ended September 30, 2019 and year ended December 31, 2018, respectively, the Company capitalized $4.1 million and $5.7 million of such development costs. As of September 30, 2019 and December 31, 2018, a total of $13.7 million and $11.7 million, respectively, of remaining unamortized development costs are reported on the Company’s Condensed Consolidated Balance Sheets. During the nine months ended September 30, 2019 and 2018, the Company recognized $1.9 million and $1.6 million, respectively, of amortization expense with regards to these capitalized software development costs, which is included in costs of services provided in the Company’s Condensed Consolidated Statements of Income.

The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 730
-URI http://asc.fasb.org/subtopic&trid=2197926

Name:	us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration